ABIOMED, Inc. (ABMD), relating to its proposed acquisition by Johnson & Johnson. Under the terms of the tender offer, ABMD shareholders will receive $380.00 in cash per share they own.
ABIOMED, Inc. (ABMD), relating to its proposed acquisition by Johnson & Johnson. Under the terms of the tender offer, ABMD shareholders will receive $380.00 in cash per share they own.